A detailed history of Daiwa Securities Group Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 1,939 shares of IDYA stock, worth $52,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,939
Previous 1,948 0.46%
Holding current value
$52,333
Previous $68,000 10.29%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.37 - $43.05 $273 - $387
-9 Reduced 0.46%
1,939 $61,000
Q2 2024

Aug 07, 2024

BUY
$34.37 - $43.46 $57,879 - $73,186
1,684 Added 637.88%
1,948 $68,000
Q4 2023

Jan 31, 2024

BUY
$24.59 - $35.83 $1,745 - $2,543
71 Added 36.79%
264 $9,000
Q4 2022

Feb 06, 2023

BUY
$14.47 - $18.17 $882 - $1,108
61 Added 46.21%
193 $4,000
Q3 2021

Nov 05, 2021

BUY
$17.26 - $27.08 $1,329 - $2,085
77 Added 140.0%
132 $3,000
Q4 2020

Feb 04, 2021

BUY
$12.17 - $17.52 $669 - $963
55 New
55 $1,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.3B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.